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Transoesophageal echocardiography (TOE) is a standard and indispensable technique in clinical practice. The present recommendations rep-
resent an update and extension of the recommendations published in 2001 by the Working Group on Echocardiography of the European
Society of Cardiology. New developments covered include technical advances such as 3D transoesophageal echo as well as developing appli-
cations such as transoesophageal echo in aortic valve repair and in valvular interventions, as well as a full section on perioperative TOE.
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Introduction
Since its introduction in the 1980s, transoesophageal echocardio-
graphy (TOE) has become a standard and indispensable technique
in clinical practice. It should be available in every echocardiographic
laboratory as well as in every centre performing cardiac surgery.
The present recommendations represent an update and extension
of the recommendations published in 2001 by the Working Group
on Echocardiography of the European Society of Cardiology,1 the
precursor of the present European Association of Echocardiogra-
phy. Technology has evolved considerably, as multiplane TOE has
become standard and real-time three-dimensional TOE is now
increasingly used. Large clinical experience has been gathered in
all typical indications, including the universal acceptance of TOE
as an important intra-operative tool especially in valve repair.2
As stated in 2001, these recommendations are not intended as a
comprehensive review of the technique, which is available in
many textbooks, but rather as a statement of current standards
in indications, patient preparation and safety precautions, and per-
formance of the procedure according to diagnostic requirements.
Training and competence
In order to provide patients with a clinically useful TOE, the oper-
ator must be competent in the procedure, the environment and
supporting team must be appropriately equipped and trained,
and a programme of quality control should be in place to ensure
the validity and reproducibility of the reports issued. Individual
competence requires acquisition of knowledge and practical skill
during a period of supervised training. Few data exist on the
amount of training required to achieve competency, but a
number of organizations have specified the contents of a training
programme. Evidence of competency is established through com-
pletion of a training programme, but specific accreditation in TOE
is being increasingly recognized. The joint European Association of
Echocardiography (EAE) and European Association of Cardio-
thoracic Anaesthesiologists (EACTA) accreditation requires indi-
viduals to train under a supervisor, to pass a multiple choice
question exam testing theoretical knowledge and image interpret-
ation, and to submit a log book of 125 procedures undertaken (75
if the applicant already holds transthoracic echo accreditation). The
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reports are graded by external examiners. Individual competence
must be maintained by continuing practice and learning.3 EAE/
EACTA accreditation is valid for a period of 5 years and then
re-accreditation requires submission of evidence of continued
practice and learning on a 5-yearly basis. Table 1 lists the require-
ments of different organizations for competence or accreditation
together with the requirements for re-accreditation in TOE.
Minimum standards for a TOE echo laboratory have been estab-
lished by the EAE,4 with recommended minimum room sizes of
20 m2, cleaning and sterilizing equipment, suction, oxygen supply,
resuscitation equipment with facilities to monitor ECG, blood
pressure, saturation, and recover patients after TOE. Room size
may be less relevant in theatres or in intensive care units.
Quality control is an important criterion for accrediting TOE
laboratories.
Indications
In general, TOE is indicated whenever the transthoracic examin-
ation is inconclusive and the potential new information is impor-
tant enough to warrant the very small risk and moderate
discomfort of the procedure. Typically, this involves clinical ques-
tions about cardiovascular structures that are not seen well or
not seen at all from the transthoracic approach, such as the left
atrial appendage, the pulmonary veins, the atrial septum, or the
thoracic aorta, and also clinical questions where the best available
image quality is of crucial importance, such as in infective endocar-
ditis or the assessment of prosthetic valves.5,6 In patients who are
extremely difficult to examine transthoracically (e.g. postoperative
and ventilated patients), this may include classic indications for
transthoracic echocardiography, such as the evaluation of left ven-
tricular function. The principal indications are given in Table 2. Fur-
thermore, an important field for TOE is intra-operative monitoring
during cardiac surgery or peri-interventional imaging, e.g. in percu-
taneous valve interventions or positioning of occluding devices for
atrial septal defects, patent foramen ovale, ventricular septal
defects and paraprosthetic leaks, or electrophysiological
procedures.
Risks and precautions
Serious complications of TOE are very rare.7,8 A recent review
listed four deaths attributed to the procedure in over 40 000
TOE examinations. Major complications included laryngospasm,
arrhythmias including cardiac arrest, oesophageal perforation, and
haemorrhage from oesophageal tumour.8 For comparison, a
recent gastroenterological survey of over 100 000 cases of upper
gastrointestinal endosonographic procedures found a mortality of
0.01% and a perforation rate of 0.03%.9 Any true resistance to
introduction of the probe, which may occur due to entrapment
of the probe tip in the piriform recess, an oesophageal diverticu-
lum, an oesophageal obstruction, e.g. a tumour, or due to hiatus
hernia, should be respected and the procedure aborted. Upper
endoscopy should then be performed prior to a new attempt.
Note that oesophageal perforation may manifest in a delayed
fashion with fever, neck pain, and subcutaneous emphysema.
Death during or immediately after TOE has been reported in
patients with acute aortic dissection, where the putative mechan-
ism was retching and an attending sharp surge in blood pressure.
Therefore, in the context of aortic dissection, blood pressure
must be tightly controlled during the procedure by administration
of sedatives and/or titration of blood pressure. Anticoagulation or
thrombocytopenia entail an enhanced bleeding risk but are not
absolute contraindications to TOE. Bradycardia or tachycardia
may occur, especially during probe introduction. Sedation may
lead to hypoxia and apnoea. If sedatives are used, after TOE
patients should be allowed to recover in the recumbent position
under surveillance. Duration of effect depends on sedative type
and dose and for midazolam typically ranges between 20 and
80 min, although assessment of recovery should be individua-
lized.10,11 Rarely, methemoglobinaemia due to the topical anaes-
thetic agents prilocaine and benzocaine, in particular, has been
observed.12 Endocarditis prophylaxis is not recommended for
TOE; however, instrument cleaning and disinfection prescriptions
must be observed carefully. Electrical current leakage may occur
after damage to the probe, such as from the patient’s teeth; there-
fore, the probe has to be inspected after each use for damage. Per-
iodic leakage current tests are also recommended by the
manufacturers.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Studies required to achieve competence/undertake accreditation of various organizations and their
re-accreditation requirements, together with web source
Organization Studies Exam Re-accreditation (studies/CME)
EAE/EACTA accreditation, www.escardio.org 125 (75 if TTE accredited) Yes 50 studies/year and 30 h CME over 5 years
ACC/ASE guidance, http://www.asefiles.org/COCATS.pdf 125 (TOE) 150 (Intraop) N/A –
NBE TOE accreditation, www.echoboards.org 300 Yes After 10 years; .50 in 2 of last 3 years;
15 h CME in last 3 years
ACTA; BSE accreditation; www.bsecho.org 125 (75 if TTE accredited) Yes After 5 years; 40 studies/year and 15 h CME
over 5 years
ACTA, Association of Cardiothoracic Anaesthetists; ASE, American Society of Echocardiography; ACC, American College of Cardiology; BSE, British Society of Echocardiography;
CME, continuing medical education; EACTA, European Society of Cardiac Anaesthesiologists; EAE, European Association of Echocardiography; N/A, not applicable; NBE, National
Board of Echocardiography (USA); TTE, transthoracic echocardiography.
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It is mandatory to ask every conscious patient in advance about
swallowing problems and any history of oesophageal disease,
such as strictures, diverticula, tumours, or recent gastro-
oesophageal surgery. A discussion with the patient about the
procedure, risks, and benefits, including implications of topical
anaesthesia (oral intake should be avoided for 2 h after the
examination) and sedation (e.g. unfitness for driving for at least
12 h), should precede the examination. Informed consent is man-
datory in conscious patients and should be documented. At least
a 4 h fast (preferably 6 h, with clear liquids allowed until 2 h
prior to the examination) before TOE should be observed,
except in emergency situations; the possibility of diabetic gastro-
paresis should be kept in mind.
TOE should be performed with multiplane equipment. The ECG
must be monitored throughout the procedure. An intravenous line
should be in place both for sedation and in the event of compli-
cations, and a supply of oxygen as well as equipment for suction
should be at hand, especially if sedation is used. Blood pressure
and oxygen saturation monitoring, including baseline values prior
to the examination, are desirable. Dental fixtures have to be
removed, and a bite guard should be in place. Topical oropharyn-
geal anaesthesia with an agent such as lidocaine is usually given.
Sedatives should be used sparingly, if needed, especially in frail
or severely compromised patients. A typical dose in a stable
patient is 2–4 mg of intravenous midazolam (0.075 mg/kg), but
lower doses may be sufficient; other sedatives or analgesics such
as fentanyl may be used instead. Whenever sedatives are used,
availability of and experience with resuscitation equipment are
mandatory. A benzodiazepine antagonist, e.g. flumazenil (0.3–
0.6 mg), must be available. The instrument tip has to be unlocked
regarding flexion and extension during intubation of the oesopha-
gus. Awake patients are usually examined in the lateral decubitus
position, to facilitate drainage of saliva, but introduction of the
instrument is sometimes easier with the patient sitting upright. In
ventilated patients, use of a laryngoscope can facilitate oesophageal
intubation. After each examination, probes have to be disinfected,
inspected for damage, and checked for electrical safety according
to manufacturer’s guidelines.
Documentation
Video recording or digital documentation of the examination is
mandatory. A written report and a log of examinations, the use
of echo contrast, adjunctive medication, and examiners must be
kept. In the report, it is desirable (especially with computerized
report generation) to specify whether certain cardiac structures
have or have not been studied. It is mandatory to note all side
effects and complications.
General course of the examination
Unlike transthoracic echocardiography, TOE is uncomfortable for
the patient. Therefore, the duration of the examination must be
Table 2 Principal TOE indications: essential views and
structures in specific clinical situations (reproduced,
with permission, from Reference 1)
1) Search for a potential cardiovascular source of embolism
Left ventricular apex or aneurysm (transgastric and
low-transoesophageal two-chamber views)
Aortic and mitral valve (look for vegetations, degenerative changes, or
tumours, e.g. fibroelastoma)
Ascending and descending aorta, aortic arch
Left atrial appendage (including pulsed wave Doppler); note spontaneous
contrast
Left atrial body including atrial septum; note spontaneous contrast
Fossa ovalis/foramen ovale/atrial septal defect/atrial septal aneurysm;
contrast + Valsalva
2) Infective endocarditis
Mitral valve in multiple cross-sections
Aortic valve in long- and short-axis views; para-aortic tissue (in particular
short-axis views of aortic valve and aortic root) to rule out abscess
Tricuspid valve in transgastric views, low oesophageal view, and right
ventricular inflow-outflow view
Pacemaker, central intravenous lines, aortic grafts, Eustachian valve,
pulmonic valve in high-basal short-axis view of the right heart
(inflow–outflow view of the right ventricle)
3) Aortic dissection, aortic aneurysm
Ascending aorta in long- and short-axis views; note maximal diameter,
flap, intramural haematoma, para-aortic fluid
Descending aorta in long- and short-axis views; note maximal diameter,
flap, intramural haematoma, para-aortic fluid
Aortic arch; note maximal diameter, flap, intramural haematoma,
para-aortic fluid
Aortic valve (regurgitation—note mechanism, annular and aortic
diameters, number of cusps)
Relation of dissection membrane to coronary ostia
Pericardial effusion, pleural effusion
Entry/re-entry sites of dissection (use colour Doppler)
Spontaneous contrast or thrombus formation in false lumen (use colour
Doppler to characterize flow/absence of flow in false lumen)
4) Mitral regurgitation (note systolic or mean blood pressure)
Mitral anatomy (transgastric basal short-axis view, multiple lower
transoesophageal views). Emphasis on detection of mechanism and
origin of regurgitation (detection and mapping of prolapse/flail to
leaflets and scallops, papillary muscle and chordal integrity,
vegetations, paraprosthetic leaks)
Colour Doppler mapping of regurgitant jet with emphasis on jet width
and proximal convergence zone
Left upper pulmonary, and, if eccentric jet present, also right upper
pulmonary venous pulsed Doppler
5) Prosthetic valve evaluation
Morphologic and/or Doppler evidence of obstruction (reduced opening/
mobility of cusps/disks/leaflets and elevated velocities by CW
Doppler)
Morphologic and Doppler evidence of regurgitation, with mapping of the
origin of regurgitation to specific sites (transprosthetic,
paraprosthetic); presence of dehiscence/rocking of prosthesis
Presence of morphologic changes in the prosthetic structure:
calcification, immobilization, rupture, or perforation of bioprosthesis
leaflets; absence of occluder in mechanical prostheses
Presence of additional paraprosthetic structures (vegetation/
thrombus/pannus, suture material, strand, abscess, pseudoaneurysm,
fistula)
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limited, and the procedure cannot be repeated frequently. The
examiner should aim to ensure that
(1) the diagnostic goal is satisfied,
(2) the structures not well visualized by transthoracic echo are
thoroughly investigated (e.g. the left atrial appendage and the
aorta), and
(3) the study is complete.
Thus, depending on patient tolerance and circumstances, the
examiner may restrict the examination to just one critical struc-
ture, such as scanning the left atrial appendage and left atrium to
rule out thrombi before the electrical cardioversion of atrial fibril-
lation. On the other hand, in the sedated or anaesthetized patient,
a systematic and thorough approach, satisfying all three listed goals,
will ensure maximal diagnostic benefit from the procedure.
Analogous to transthoracic echocardiography, TOE views are
mainly defined by internal landmarks, not by specification of
probe position and plane angulation. Where degrees of viewing
plane are given, 08 denotes a transverse and 908 a vertical view,
with clockwise plane rotation when looking in the direction of
the ultrasound beam. Plane rotation (or switching from transverse
to longitudinal in biplane probes), shaft rotation, anteflexion, retro-
flexion, and sideward flexion of the tip, and finally probe advance-
ment and withdrawal are the manoeuvres available to the
examiner to change the view. Anteflexion flexes the tip mechani-
cally upwards anteriorly, thereby usually improving contact with
the anterior gastric or oesophageal wall, and retroflexion flexes
it upwards posteriorly, thereby often deteriorating transducer
contact with the gastric or oesophageal wall. Sideward (lateral)
flexion (to the right or left of the transducer face) can be used
instead of plane rotation to fine tune views and improve contact
with oesophageal or gastric wall, but is less important with the
use of multiplane transducers. Probe shaft rotation is described
as clockwise or counterclockwise as seen from the examiner’s
viewpoint looking down the shaft of the probe.
The following description is intended to outline a complete
examination. Pathological findings or special questions may
necessitate a more detailed examination of particular structures,
which is beyond the scope of this article.
The typical TOE examination comprises three major steps:
† the proper transoesophageal examination, which may be con-
ceptually divided into lower oesophageal views, mainly to
image the ventricles, and upper transoesophageal views,
mainly to image the valves, atria, and great vessels. However,
sharply defined transducer positions or windows do not exist,
since they vary individually and have to be adjusted for each
view. Often, upper and lower transoesophageal views can be
obtained from approximately the same transducer position by
flexing or extending the tip of the transducer, since the
optimal oesophageal window often is small.
† the transgastric examination
† the examination of the aorta.
The sequence of these elements may be chosen individually;
many operators start with transoesophageal views, followed by
transgastric views, and finally visualize the descending aorta and
aortic arch pulling the instrument back from the position in the
gastric fundus. Although any number of additional views may be
necessary to better delineate pathological findings (e.g. vegetations,
thrombi, etc.), the italicized views are essential for a complete TOE
examination, and colour Doppler, pulsed, and continuous wave
Doppler should be used as indicated.
Lower transoesophageal views
With the imaging plane in the transverse position, immediately
above the diaphragm the orifice of the inferior vena cava, the
right atrium, and the tricuspid valve are visualized in a long-axis
view (Figure 1). Adjacent to the septal tricuspid leaflet, the
orifice of the coronary sinus may be seen, which courses
upwards (towards the transducer). The anterior (or sometimes
posterior) tricuspid leaflet is seen to the left, and the septal to
the right.
Slightly further up, a (foreshortened) transoesophageal four-
chamber view is obtained (Figure 2). Sometimes a low degree of
rotation (10–208) is useful to exclude the aortic valve. The
probe should be straightened before withdrawal from the
stomach to minimize foreshortening, as long as image quality is
maintained. In the transoesophageal four-chamber view, the left
ventricle is on the right side of the sector and the right ventricle
on the left. The left atrium is on top, and septal and lateral walls
of the left ventricle, as well as the right ventricular free wall, are
seen. The anterior mitral leaflet is seen on the left and the posterior
on the right side; the septal tricuspid leaflet is on the right side and
the anterior tricuspid leaflet on the left side. The transoesophageal
two-chamber view (Figure 3) is obtained at 60–908, with the
convex anterior wall to the right, the straight inferior wall to the
left, and the apex in the far field. The posterior mitral leaflet is on
the left side and the anterior leaflet on the right side. Frequently,
the left atrial appendage is seen on the right side of the base of
Figure 1 Low transoesophageal view of right ventricle (RV),
right atrium (RA), and tricuspid valve. This is a transoesophageal
four-chamber view modified by slight counterclockwise shaft
rotation.
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the left ventricle (in the sector image). Further plane rotation brings
into view the transoesophageal long-axis view of the left ventricle
(Figure 4) at 120–1508, with the anterior mitral leaflet, the
aortic valve and ascending aorta, and the anteroseptal left ventricu-
lar segments on the right side (from near to far field), and the pos-
terior mitral leaflet and posterior left ventricular wall on the left
side. These three views of the left ventricle (four-chamber, two-
chamber, and long-axis) are the essential oesophageal views for
evaluating the left ventricle, including segmental wall motion
abnormalities. The mitral valve can be studied in detail (after
appropriate depth reduction) in the same views enumerated for
the left ventricle. The use of multiple transoesophageal cross-sections
of the mitral valve, especially with a multiplane transducer, includ-
ing spectral Doppler of transmitral flow and colour Doppler
mapping of the left atrium, allows mapping of mitral pathology
and regurgitant jet origin to leaflets and leaflet segments (scallops
in the posterior mitral leaflet). This is discussed in more detail in
the section on the mitral valve. Pulsed Doppler tracings of pulmon-
ary venous flow can be recorded from both the left and the right
upper pulmonary veins. Spontaneous echo contrast (‘smoke’) in
Figure 3 Transoesophageal two-chamber view. AW, anterior
wall; IW, inferior wall; LAA, left atrial appendage; CS, coronary
sinus.
Figure 4 Transoesophageal long-axis view of the left ventricle.
Aoa, ascending aorta.
Figure 5 Aortic valve short-axis view (ac, acoronary; lc, left
coronary; rc, right coronary cusp and sinus).
Figure 2 Transoesophageal four-chamber view. LA, left atrium.
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the left atrium and/or appendage should be noted. Since spon-
taneous echo contrast is gain-dependent, it should be ensured
that gain levels are high enough not to miss it.
Upper transoesophageal views
Flexion of the tip or withdrawal of the probe will display the aortic
valve and both atria from an upper transoesophageal position.
Short- and long-axis views of the aortic valve (Figures 5 and 6)
should be obtained by looking for a circular aortic root in the
short-axis views (at 40–708) and a central closure of the two visu-
alized aortic leaflets, as well as a maximal visualized length of the
ascending aorta in the long-axis view (at 130–1608). The short-axis
view shows the left coronary cusp in the upper right third, the non-
coronary cusp in the upper left third, and the right coronary cusp
in the lower third (anteriorly), while the long-axis view has the
non-coronary aortic cusp on top and the right coronary cusp at
the bottom (i.e. anteriorly). If the transducer is slightly withdrawn
from the aortic valve in a short-axis view, the coronary ostia can be
identified by adjusting the plane individually, located at 2 o’clock
(left coronary ostium) and 6 o’clock (right coronary ostium) of the
circumference of the aortic root. The right coronary ostium is fre-
quently visualized more easily in the long-axis view of the aortic
valve. Colour Doppler mapping should be performed in both
aortic valve views. Spectral Doppler assessment of aortic flow vel-
ocities is better achieved in transgastric long-axis views due to
more coaxial beam alignment. The maximal visualizable extent of
the ascending aorta (Figure 7) should be documented, which
necessitates withdrawal of the probe to display the upper part of
the ascending aorta (displayed on the right sector side), with an
angle between 130 and 1608, especially where the ascending
aorta courses anteriorly of the right pulmonary artery. The right
atrium, the tricuspid valve, inflow and outflow tract of the right
ventricle, the pulmonary valve, and the main pulmonary trunk
are seen in counterclockwise continuity, with the aortic valve in
the centre, in the short-axis view of the aortic valve (Figure 5).
This view (also called the right ventricular inflow–outflow view)
resembles an upside down parasternal aortic valve short-axis
view. Colour Doppler evaluation of the tricuspid and—less
satisfactorily—the pulmonary valve can be performed. If visualiza-
tion of the distal right ventricular outflow tract, the pulmonary
valve, and the proximal main pulmonary artery are of particular
interest, a plane rotation to a lower angle (100–1308) or counter-
clockwise shaft rotation brings these structures into view.
From an upper transoesophageal window, the atrial septum with
the oval fossa should be visualized in at least two planes (trans-
verse and longitudinal or sagittal view). The transverse view of the
right atrium is usually a minor modification of the transoesophageal
four-chamber view with reduced depth. It shows the left atrium on
top, the atrial septum as approximately horizontal structure, and
the tricuspid valve to the right. Neither caval vein is seen in this
view. The longitudinal, sagittal, or bicaval view of the right atrium
(at 908; Figure 8) displays the orifices of the superior (right
sector side) and inferior caval veins (left sector side) and the
right atrial appendage; the tricuspid valve is not seen. This view
allows in particular the evaluation of atrial septal defects of
Figure 6 Aortic valve long-axis view (magnification).
Figure 7 Long-axis view of the ascending aorta. (A) Proximal ascending aorta. (B) In the same patient, after retraction of the probe and adjust-
ment of the plane orientation, a long portion of the dilated ascending aorta is seen. RPA, right pulmonary artery.
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secundum type, the foramen ovale, pacemaker leads, and intrave-
nous lines. If patency of the foramen ovale is to be checked,
echo contrast should be applied and monitored during
spontaneous breathing and, importantly, on release of a Valsalva
manoeuvre.
Views of cranial structures of the heart and great vessels are
obtained by withdrawing and anteflecting the probe in the trans-
verse (08) plane from a position showing the mitral valve in the
centre of the sector. On the right side of the screen, the left
atrial appendage is seen (Figure 9); careful study of this structure
which varies in size, shape (e.g. presence and number of distinct
lobes), and orientation often requires additional plane rotation
between 0 and 908. Pulsed wave Doppler recording of appendage
flow is useful to assess the risk of thrombus formation. Further
withdrawal and anteflexion displays the left upper pulmonary vein
(Figure 10). Clockwise shaft rotation displays the short-axis view of
the ascending aorta, accompanied on the left side by the superior
vena cava (Figure 11), and on the right side by the main pulmonary
artery. The right pulmonary artery courses to the left side of the
sector posteriorly of the ascending aorta. The left pulmonary
artery is poorly seen and courses to the right side of the sector.
The orifice of the right upper pulmonary vein is seen at the junction
of right atrium and superior vena cava and posterior to the latter,
both in transverse and longitudinal views (Figure 12). This junction
is the location of the transthoracically often poorly visualized sinus
venosus atrial defects. In a longitudinal (908) view, the orifice of the
right upper pulmonary vein can be located between left atrium and
right pulmonary artery.
Figure 8 Left and right atrium and atrial septum in longitudinal
(sagittal) view. Note orifice of superior (SVC) and inferior vena
cava (IVC) and right atrial appendage (RAA).
Figure 9 (A) Left atrial appendage. (B) Pulsed wave Doppler recording of emptying (upward) and filling (downward) velocities in atrial fibrilla-
tion. The velocities are quite high (.25 cm/s), indicating relatively low risk of thrombus generation. LUPV, left upper pulmonary vein.
(C ) Example of left atrial appendage with marked pectinate muscles (arrow). There is no thrombus.
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The transducer is positioned in the upper stomach (gastric fundus),
enabling left ventricular short-axis and two-chamber views (Figures 13
and 14). In the left ventricular short-axis view at the mid-papillary
level (at 08), the anterolateral papillary muscle is seen at 5
o’clock and the posteromedial approximately between 11 and 2
o’clock. The free wall of the right ventricle is seen on the left
sector side. Counterclockwise, the mid-segments of the septal,
anteroseptal, anterior (farthest from the transducer), lateral,
posterior, and inferior (closest to the transducer) left ventricular
walls are seen. In the left ventricular two-chamber view (at 908),
the inferior wall is seen in the near field of the sector and the
anterior wall at the bottom of the sector. The apex, which often
is not well visualized, is to the left and the mitral valve to the
right of the sector. Wall motion abnormalities, thrombi, and path-
ology of the subvalvular mitral apparatus, which is particularly well
displayed in the transgastric two-chamber view, should be noted.
The long-axis view of the left ventricle, with assessment of
left ventricular outflow tract and aortic valve, is obtained at
100–1208 and sometimes minor clockwise shaft rotation
Figure 10 Left: left upper pulmonary vein (LUPV) imaged in an approximately longitudinal view. Right: pulsed Doppler recording of normal
pulmonary venous inflow from the left upper pulmonary vein. Positive (upward) velocities are directed into the left atrium. S, systolic wave; D,
diastolic wave; R, reverse wave.
Figure 11 Short-axis view of ascending aorta and main pul-
monary artery (MPA), with bifurcation and origin of right pulmon-
ary artery (RPA), from the upper transoesophageal window.
Figure 12 Transverse view of upper left atrium. Colour
Doppler display of inflow from right upper pulmonary vein
(RUPV, arrow). SVC, superior vena cava; AoA, ascedending aorta.
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(Figure 15). The aortic valve is seen in the far field. Elevated or
reversed flow velocities in the outflow tract or through the aortic
valve should be documented. It is frequently difficult to achieve
this view, and the ascending aorta is not seen well. Additionally, or
alternatively in case of difficulty in obtaining the long-axis view of
the left ventricle from the typical transgastric position, a deep trans-
gastric long-axis view or five-chamber view (Figure 16), including the
aortic valve, can be obtained by advancing the probe further into
the gastric fundus and using maximal anteflexion of the probe.
Note that this view will display cardiac structures roughly like a
transthoracic apical four-chamber view, i.e. upside down compared
with the transoesophageal four-chamber view. Rotation to 60–908
creates a modified transgastric apical long-axis view of the left ven-
tricle. These views are particularly useful for the Doppler examin-
ation of the left ventricular outflow tract and aortic valve.
A short-axis view of the mitral valve (Figure 17) is obtained further
basally from the mid-papillary muscle short-axis view by slightly
withdrawing and anteflexing the instrument, and sometimes
adding 10–208 of rotation. The origin of mitral regurgitation jets
by colour Doppler, as well as flail or prolapsing portions, and sys-
tolic anterior motion of the leaflets, can be detected in this view.
Although this view is often not easy to obtain, it is very helpful
in assessing the origin of mitral regurgitant jets.
Additional views of the right heart, which are not routinely
obtained, but are important whenever right heart pathology has
to be evaluated, are generated by rotating the probe from the
transgastric left ventricular short-axis position to the right, posi-
tioning the right ventricle in the centre of the sector, and steering
the plane angulation first to 308, producing a short-axis view of
the tricuspid valve, with the posterior leaflet to the upper left, the
septal leaflet to the upper right, and the large anterior leaflet in the
lower half of valve cross-section. A right ventricular inflow view
can be obtained by further rotation. At 908, a long axis of the
right ventricular inflow is seen, which is analogous to the left ven-
tricular two-chamber view in that the apex is to the left and the
right atrium to the right. Further rotation discloses the right ventri-
cular outflow tract, with the pulmonary valve located at the
bottom of the sector.
Aortic views
Unless aortic pathology is the primary indication for a study, the
thoracic aorta is usually examined at the end of the TOE after
the cardiac examination. Between the upper abdomen and the
aortic arch, the oesophagus and the descending aorta change
their anterior–posterior relationships (at the diaphragm the oeso-
phagus lies anterior to the aorta; at mid-thorax it is medially
located; at the aortic arch it is posterior). Therefore, the complete
length of the thoracic descending aorta should be scanned in the
short-axis view (supplemented by long-axis views) by gentle rotation
of the probe to maintain correct visualization of aortic walls along
the entire course of the vessel (Figure 18). The take-off of the left
subclavian artery can usually be seen, and often part of the distal
Figure 13 Transgastric short-axis view of the left (LV) and
right ventricle (RV).
Figure 14 Transgastric two-chamber view. The apex is to the left, and the left atrium to the right in the image. (A) Cross-section showing the
cavity of the left ventricle. (B) Slightly modified view intersecting both papillary muscles and chordal subvalvular apparatus. AW, anterior wall;
IW, inferior wall; AL, anterolateral papillary muscle; PM, posteromedial papillary muscle.
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arch and the supra-aortic branches can be visualized; probe shaft
rotation may be useful to adjust the images. Clockwise rotation
and slight probe withdrawal at the junction of aortic arch and des-
cending aorta display the long axis of the aortic arch, with the
anterior aortic arch wall in the far field of the sector, and partially
the superior ascending aorta. At 908, a short axis of the aortic arch
is obtained. By rotating the transducer and advancing further into
the oesophagus, the distal portion of the ascending aorta may be
recorded. However, due to the interposition of the trachea or
left main bronchus, some portion of the arch or distal ascending
aorta will usually not be visualized. The location of findings in
the descending aorta can be described either by the distance of
the probe tip to incisors, or by the cardiac structures at the
same distance.
Assessment of the mitral valve
Anatomically, it is standard practice to divide each mitral leaflet
into three segments, defined by dividing the attachment of each
leaflet to the atrioventricular junction (annulus) into three equal
parts, and then by dropping perpendicular lines to the closure
line of the valve (Figure 19). The body of the anterior leaflet is a
single structure which is attached along approximately one-third
of the circumference of the annulus, between the fibrous trigones.
The ‘posterior’ leaflet occupies the lateral and inferior parts of the
left atrioventricular junction and is attached along approximately
two-thirds of the circumference of the mitral annulus. Usually,
the posterior leaflet has three scallops, but their size and also
the number of scallops can vary. It is difficult even with TOE to
identify the clefts between the scallops precisely, and so an echo-
cardiographic approximation of the site of disease to the lateral,
middle, or medial thirds of the posterior mitral leaflet (P1, P2,
and P3, respectively) may not correspond exactly either with the
precise anatomy of the scallops or with the exact location of find-
ings on surgical inspection. 3D TOE provides en face views of the
mitral valve as if seen by the surgeon after left atriotomy, which are
felt to be advantageous for communication with the surgeon due
to their intuitive appeal; see corresponding section below.
Detailed echocardiographic assessment of the mitral valve leaf-
lets should be performed using 2D imaging planes that show the
leaflet tips in a long-axis orientation. Because TOE provides a mul-
titude of possible cross-sections through the mitral valve, a sys-
tematic reference framework is necessary for orientation. One
way to analyse the mitral anatomy is by rotating the orientation
of the image through 3608 (Figure 20). However, to show the
anatomy well and completely, this requires to position the probe
so that the pivot around which all the imaging planes are rotated
lies at the centre of the annulus. This requirement is often difficult
or impossible to fulfil with sufficient image quality. Therefore, plane
Figure 16 Deep transgastric long-axis view of the left ventri-
cle, with maximal anteflexion. RV, right ventricle.
Figure 15 Transgastric long-axis view of the left ventricle
(1178). AoA, ascending aorta.
Figure 17 Short-axis view of the open mitral valve from the
transgastric position. AL, anterolateral; PM, posteromedial com-
missure. A1–A3 and P1–P3 denominate the respective leaflet
scallops.
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rotation alone often is not sufficient and should be supplemented
by systematically analysing parallel planes as depicted in Figure 20.
The classification of mechanisms of regurgitation that is most
commonly used by cardiac surgeons was developed by
Carpentier13 (Table 3). It is based on the relative mobility of all
the segments of both leaflets, compared with the mobility and
position of the leaflets next to the anterolateral commissure
taken as a reference point. However, this concept originally
stems from surgical inspection while the patient is on cardio-
pulmonary bypass and when the heart is flaccid due to cardiople-
gia; for this reason, it is recommended that additionally the regional
pattern of closure of the mitral valve leaflets is described in terms
of coaptation (whether or not the leaflets touch each during
systole) and apposition (whether or not the leaflets are symmetri-
cally aligned opposite each other in systole).
In systole, the mitral annulus is not planar but saddle-shaped, with
high points that are anterior and posterior and low points that are
lateral and medial. Similar to transthoracic imaging, a transoesopha-
geal four-chamber view crosses through the low points of the
annulus and thus is more likely to display prolapse than are apical
two-chamber or long-axis images which cross the mitral annulus
at its high points. As in transthoracic imaging, mitral valve prolapse
should only be diagnosed confidently when the mitral leaflets
appear beyond the plane of the annulus in longitudinally orientated
images, i.e. long-axis views. When mitral regurgitation is provoked by
chronic dilatation of the left ventricle or during acute ischaemia,
increased traction and downwards and outwards displacement of
the subvalvar apparatus increase the distance between the bodies
of the mitral leaflets and the plane of the annulus and reduce the
overlap of the tips of the leaflets (apposition of the rough zones).
This is termed secondary, functional, or ischaemic mitral regurgita-
tion. These changes can be quantified by measuring the ‘tenting’
area or volume (by 2D or 3D echo, respectively), or simply by the
distance between the coaptation point of the leaflets and the
plane of the annulus (the tenting height14,15). In this type of mitral
regurgitation, there are likely to be multiple regurgitant jets arising
along a large portion of the closure line. If no clear regurgitant
pathology is identified and if the annulus and tenting height are
normal, then alternative explanations such as a perforated leaflet
or a cleft should be considered.
During TOE, the severity of mitral regurgitation should be
graded using the same criteria recommended for transthoracic
imaging.16,17 When performing grading of residual regurgitation
compared with preoperative regurgitation in the operating room
after bypass, it is important to ensure that left ventricular function
and blood pressure have recovered, the Nyquist limit and gain set-
tings for colour Doppler have been kept constant, and that frame
rates for colour Doppler are maximized. In the anaesthetised
patient with low blood pressure, the severity especially of func-
tional mitral regurgitation is typically underestimated. Systolic
Figure 18 Descending aorta: (A) short-axis view; (B) long-axis view. The aorta shows atherosclerotic lesions, some of which (arrow) have
superimposed mobile thrombus.
Figure 19 Pathologic specimen of the closed mitral valve, seen
from the atrial side (‘surgeon’s view’). A1–3 and P1–3 designate
the leaflet scallops. The yellow triangles indicate the site of the
fibrous trigones; the dotted black lines show the most common
location of the fibrous mitral annulus. Opposite P2 the mitral
annulus is usually composed only of ventricular myocardium. S,
superior; I, inferior; L, left; R, right. Courtesy of JRTC Roelandt,
Rotterdam, The Netherlands.
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blood pressure should be recorded during any echocardiographic
study of the severity of mitral regurgitation, whether before or
during cardiac surgery. It is not necessary to perform pre-operative
TOE in all patients before mitral valve surgery; if transthoracic
images are of sufficient quality for a detailed diagnosis to be
made, then TOE can be postponed until the patient is anaesthe-
tized prior to surgery.
Mitral prostheses should be assessed in a similar fashion to the
native mitral valve; here, it is often easy to use mainly systematic
plane rotation from a fixed viewing point in order to assess the pros-
thesis and its circumference. This is particularly valuable to localize
and quantify the size of paraprosthetic leaks. Occluder motion is
well assessed, thrombi or vegetations identified, and colour
Doppler as well as continuous wave Doppler examination for regur-
gitation or obstruction performed. However, structures on the ven-
tricular side of the prosthetic ring or occluder may be masked by
shadowing. For 3D assessment see the corresponding section.
Percutaneous interventions in mitral regurgitation have opened
a new field for TOE guidance and surveillance, which will possibly
further benefit from 3D imagery. In the EVEREST I safety and feasi-
bility trial, TOE was successfully used for this purpose as the
primary imaging modality.18
Assessment of the aortic valve
and aortic root
TOE is used for assessing the aortic valve in several frequent scen-
arios, including but not restricted to, endocarditis (Figure 21),
improved characterization of stenotic or regurgitant lesions,
aortic prosthetic malfunction, preparation for aortic valve
surgery (especially if repair is contemplated), aortic interventions,
or in the context of dissection of the ascending aorta.
The main views to assess aortic valve and root morphology, which
are long- and short-axis views of these structures, have been
Figure 20 Examination of the mitral valve. Screen depiction of relative position of mitral leaflets and segments/scallops in typical transoesopha-
geal cross-sections created by three different examination manoeuvres. Note that individual anatomy, especially scallop morphology, is variable,
and so is the relation of image plane orientation to individual anatomy; the schematic drawings should therefore be understood as approximations.
A1–A3, anterior leaflet segments; P1–P3, posterior leaflet segments; Ao, aortic valve; LAA, left atrial appendage. (A) Examination by rotation of
imaging cross-section with fixed transducer position positioned at the level of the mitral valve centre. (B) Examination by flexion/withdrawal and
retroflexion/advancement of the transesophageal transducer, while rotation angle is fixed in a transverse orientation (08). (C) Examination by
probe shaft rotation (counterclockwise from plane A to C), while rotation angle is fixed in an orientation approximating the mitral closure line
(45–908). Note that the aortic valve is not imaged in these planes. Reproduced, with permission, from Foster et al.47
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reviewed previously in this text. Doppler assessment by continuous
or pulsed wave Doppler can only be obtained with good alignment
between ultrasound beam and flow direction using a deep transgas-
tric long-axis view (Figure 16). The normal aortic valve is composed
of three cusps, surrounded by a dilatation of the aortic wall called the
Sinus Valsalvae. Each of the cusps is named according to the coron-
ary ostium in the corresponding sinus. Congenital abnormalities of
the aortic valves include the bicuspid valve, sometimes associated
with co-arctation of the aorta or with dilatation of the aortic root,
and rarely the unicuspid or quadricuspid valve. Several types of
bicuspid aortic valves may be distinguished according to the pres-
ence and location of the raphe.19
Although aortic valve replacement remains the most frequent
treatment for aortic valve stenosis, repair techniques are increas-
ingly used for the treatment of aortic regurgitation.20 Therefore,
an accurate diagnosis of the mechanism of valve dysfunction is a
key point for determining the feasibility of the technique and
guide the decision for repair of replacement of the aortic valve.
TOE assessment of the aortic valve must always take into
account the characteristics of the aortic root. The aortic valve,
aortic root, and left ventricular outflow tract should be inspected
in short- and long-axis views. Subvalvar (Figure 22) or supravalvar
stenosis is visualized especially in the long-axis view. The normal
aortic valve is very thin and may be difficult to image specially in
diastole in long-axis view. A bicuspid or stenotic valve may
display ‘doming’ in the long-axis view. Presence, location, and
severity of calcifications on the free margins of the leaflet bodies
can be evaluated best in the short-axis view. This view is also
used for the measurement of aortic valve orifice area by planime-
try. To allow precise measurements, the cross-sectional plane
must contain the smallest orifice of the valve and thus the probe
position and orientation must be adjusted to obtain the smallest
valve orifice area at tips of the leaflets, which is of particular impor-
tance in the doming valve. Use of biplane or 3D TOE may help
locate the right position for planimetry. A key point in considering
repair of the aortic valve is the mobility of the aortic leaflets.
Restricted motion due to calcification suggests valve replacement
rather than repair. On the other hand, regurgitation due to exces-
sive tissue motion, as in prolapse, is more amenable to repair. Pro-
lapse of aortic leaflets may be defined analogously to mitral valve
prolapse as diastolic displacement of an aortic leaflet (or part
thereof) towards the left ventricle beyond the plane of the
aortic annulus in diastole. The diagnosis is made in long-axis view
but precise location requires frequently the use of short-axis
view and back-and-forth rotation between these two standard
views, particularly when pathology involves the ‘upper’ leaflet in
long-axis view which may be the non-coronary or the left coronary
leaflet. Several kinds of prolapse exist (Figure 23):
† flail leaflet, when there is no more leaflet coaptation and the
leaflet is ‘floating’ in the outflow tract, often with a ‘spoon’
appearance;
† prolapse proper of a leaflet, when the leaflet body is displaced
below the level of the annulus plane and thus coaptation
length is severely reduced allowing regurgitation during diastole;
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .




























Figure 21 Infective endocarditis of bioprosthesis in aortic position, with paraprosthetic abscess characterized by aortic wall thickening with
central zone of reduced reflectivity (arrows). (A) Long-axis view. (B) Short-axis view.
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† partial leaflet prolapse, when only part of a leaflet is prolapsing;
frequently the leaflet is divided in two parts by a fibrous band,
and only the free margin portion prolapses.
Colour Doppler localizes the origin and course of aortic regurgi-
tant jets, e.g. a central jet due to central loss of coaptation, or a com-
missural or eccentric jet due asymmetric leaflet restriction or a
leaflet prolapse. In the presence of a prolapse, colour Doppler
flow exhibits eccentric aortic regurgitation away from the prolapsing
leaflet, which may help identify the location of the prolapse
(Figure 23). Diastolic coaptation of the valve is well seen in the short-
axis view. Loss of central coaptation is associated with aortic insuf-
ficiency and usually the consequence of aortic root dilatation.
The aortic root, best assessed in long-axis views, is the proximal
part of the ascending aorta comprising the sinus of Valsalva located
above the valve and the sinotubular junction, which is the nar-
rowed portion just above the sinus of Valsalva making the junction
with the tubular part of the root (ascending aorta). Dilatation of
the aortic root frequently causes aortic regurgitation and is a
risk factor for aortic dissection. Several long-axis view diameter
measurements are helpful in characterizing the aortic root and
ascending aorta (Figures 24 and 25). Dilatation of the aortic root
can be located at the level of the sinus of Valsalva, the sinotubular
junction or the tubular portion of the ascending aorta; precise
location is important to guide the surgeon for the repair
Figure 22 Subvalvular aortic stenosis due a subaortic mem-
brane. Long-axis view.
Figure 23 Prolapse and flail of the aortic valve; long-axis views. (A) Flail leaflet. (B) Whole cusp prolapse. (C) Partial cusp prolapse, fibrous
band highlighted by arrow. (D) Colour Doppler corresponding to case C, showing eccentric regurgitant jet.
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procedure. Dilatation of the aortic root is sometimes associated
with bicuspid aortic valve and Marfan’s disease, but most frequently
related to age or hypertension. Reference dimensions of the aortic
root have been published.21
Aortic dissection can induce aortic regurgitation by several
mechanisms:22 dilatation of the ascending aorta, rupture of the
attachment of a cusp, or prolapse of the dissection flap through
the aortic valve. Correct identification of the mechanism by TOE
may prevent unnecessary aortic valve replacement.
Aortic valve prostheses are assessed in the same views as native
aortic valves, and multiple views are necessary to minimize the
impact of acoustic shadowing. In mechanical valves, obstruction
may occur by thrombosis or pannus (fibroconnective tissue).
Restricted occluder motion may lead to both obstruction and regur-
gitation. However, it is not always possible to detect and quantify
restricted occluder motion in aortic prostheses by TOE.23 Degener-
ated bioprostheses may develop stenosis by thickened and immobi-
lized leaflets. While TOE provides good assessment of leaflet
morphology and mobility, gradients are often better obtained trans-
thoracically. By TOE, they can best be recorded in a transgastric
long-axis view or in a deep transgastric five-chamber or long-axis
view. Regurgitation in the presence of an aortic prosthesis can be
transprosthetic, paraprosthetic, or both. Short-axis views at the
level of the sewing ring allow best to differentiate transprosthetic
and paraprosthetic leakage. If a paraprosthetic leak is large (dehis-
cence), it may compromise the stability of the sewing ring, leading
to rocking of the whole prosthesis. For details of functional evalu-
ation of prosthetic valves see reference 6.
Prosthetic infective endocarditis is characterized by vegetations
which in mechanical prostheses are usually attached to the pros-
thetic ring, while in bioprostheses they may also arise from the leaf-
lets. An echo free space or localized aortic wall thickening next to
Figure 24 Typical measurements of the aortic root apparatus.
ST, sinotubular.
Figure 25 (A) Dilatation of the sinus of Valsalva. (B) Effacement of sinotubular junction. (C) Dilatation of the ascending aorta.
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the prosthetic sewing ring is highly suspicious of an abscess
(Figure 21), typically in the region of the non-coronary sinus of
Valsalva.
An emerging application of TOE relates to interventional or trans-
catheter (transapical or transfemoral) aortic valve replacement.24,25
Before intervention, the aortic annulus diameter is of critical impor-
tance for selection of prosthetic size. Implantation can be TOE-
guided, although deployment of the prosthesis in most laboratories
relies more heavily on fluoroscopy. Immediately after deployment,
TOE is essential to evaluate aortic regurgitation, which if severe
and paraprosthetic may prompt re-insufflation of the deployment
balloon in the prosthesis in order to improve apposition of the pros-
thetic ring to the aortic wall.
Three-dimensional (3D) TOE
The recent advent of 3D imaging has considerably enhanced TOE
by providing relatively high image quality and several unique views,
and by its capability to show intuitively understandable 3D images
to physicians not specialized in imaging. The one already commer-
cially available 3D TOE probe besides 3D imaging provides the
same modalities as a standard transoesophageal transducer (2D
imaging and all Doppler modalities). 3D imaging can be performed
in several modes:
† Real-time, simultaneous biplane imaging (‘X-plane’), typically
orthogonal, but plane orientations can be changed; includes
colour Doppler.
† Real-time (‘live’) 3D, where a real-time 3D data set is obtained
and displayed. The sector angle is lower than that of the typical
2D sector and depends on the desired scan line density.
† A zoom modality for real-time 3D.
† A modality encompassing the classic full sector width (‘full
volume’), but necessitating previous acquisition of several
heart cycles and therefore not fully ‘live’; this option can also
be used with colour Doppler.
3D frame rates are relatively low (25–28 per s in ‘full volume’,
higher for data sets recorded with a narrower sector angle). To
obtain good quality, images should first be optimized in 2D
mode, with special emphasis on gain (too much gain will loose
the 3D feel and too little gain will result in ‘holes’) and com-
pression (2D compression not too low, then adjust 3D com-
pression if necessary). For 3D zoom, after 2D optimization the
3D ‘zoom box’ should be adjusted to include the structure of
interest in the smallest volume possible in order to have a frame
rate as high as possible. For 3D ‘full volume’, after 2D optimization,
it is recommended to switch to ‘live 3D’ mode to adjust 3D gain,
volume size, and frame rate, followed by the full-volume 3D
volume acquisition in a short breath hold. Similarly, for 3D
colour Doppler imaging, colour Doppler gain, scale and wall
filter should first be optimized in 2D and live 3D before final 3D
acquisition. The most frequent indications for 3D TOE are
† mitral valve disease,26 –29 especially mitral regurgitation second-
ary to mitral valve prolapse (Figures 26 and 27). The main advan-
tage of 3D TOE is the accurate identification of location and
extension of valve pathology (e.g. flail leaflet portions),
particularly in en face views (‘surgeon’s view’) with a viewpoint
in the left atrium looking towards the left ventricular apex.
† Aortic valve disease.28 The best 2D view for launching the 3D acqui-
sition is a long-axis view. The ‘zoom box’ should include the whole
aortic valve, but should not include much of the ascending aorta. 3D
TOE helps to planimeter the valvular orifice area in aortic stenosis
and the regurgitant orifice area in aortic regurgitation.
† Prosthetic valves (Figure 28). One of its main advantages is the
determination of location and extension of paraprosthetic
leaks.28
† Congenital heart disease.30 To obtain atrial septal images of the
atrial septum, bicaval or the best 2D cross-section showing
the defect should be used; the 3D acquisition should include
the whole atrial septum. Left and right upper pulmonary veins
are well visualized using the 3D zoom.
† Guidance of percutaneous interventional procedures,26,27
especially closure of paraprosthetic leaks and atrial septal
defects, and interventional valvular procedures.
Perioperative TOE
Perioperative TOE was introduced into clinical practice in the early
1980s. The first reports were concerned with the assessment of left
ventricular function and the detection of intra-operative air
embolus.31–34 Since that time, there has been an exponential
growth in the use of TOE in surgical patients. The result is the
current situation where TOE skills are widespread among cardiac
anaesthesiologists, and are developing among those anaesthesiologists
and others involved in major surgery, particularly neurosurgery, liver
transplantation, vascular surgery, trauma surgery, and in critical care.
A growing body of articles and several guidelines, most recently the
Practice Guidelines for Perioperative Transoesophageal Echocardio-
graphy update35 reflect the broad use of perioperative TOE by
anaesthesiologists.
Figure 26 3D transoesophageal en face view of the mitral
valve with a P2 prolapse, seen from a left atrial viewpoint (3D
zoom). A2, anterior leaflet opposite to P2; AV, aortic valve
region.
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In every surgical setting, the role of TOE is to confirm or further
define the preoperative diagnosis, exclude any new deterioration
or unsuspected pathology, facilitate the intra-operative manage-
ment of the patient, including where necessary to aid in surgical
planning, and to evaluate the results of surgery and provide infor-
mation for the postoperative care of the patient.
Cardiac surgery
Cardiac surgery represents the largest clinical arena for periopera-
tive TOE. Evidence for the indications for TOE has evolved over
time. The lack of randomized controlled trials and meta-analyses
has necessarily led to a cautious approach, most evident in the rec-
ommendations of the 2003 ACC/AHA guidelines.36 These stated a
Class I recommendation for TOE in a range of cardiac surgical con-
ditions including valve repair and complex valve replacement, most
congenital heart surgery, complex endocarditis, complex pericar-
dial drainage, aortic dissection, and intracardiac device placement.
They also recommended TOE as a Class I indication for the evalu-
ation of acute, persistent, and life-threatening haemodynamic dis-
turbances in the perioperative setting. However, a number of
other cardiac surgical procedures were identified as Class II indi-
cations, including surgical procedures in patients at increased risk
of myocardial ischaemia, myocardial infarction, or haemodynamic
Figure 27 3D transoesophageal view of the jet of severe mitral regurgitation due to posterior mitral prolapse, seen from a left atrial per-
spective (‘full volume’, colour Doppler mode); LA, left atrium. (A) Diastolic frame, with open mitral valve. Note laminar blue inflow into the left
ventricle across the valve. (B) Early systolic frame with incipient formation of turbulent jet in the left atrium. (C) Mid-systolic frame. The
eccentric jet follows the concavity of the atrial wall. (D) Late systole: maximal size of colour Doppler representation of regurgitant jet.
Figure 28 3D transoesophageal view of bileaflet mitral pros-
thesis from the atrium; the discs are in the open position. LAA,
left atrial appendage; AO, location of ascending aorta.
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disturbances. Arguably, this risk could be said to be relevant to all
adult cardiac surgery patients, particularly in contemporary surgical
practice where both the age and clinical state of patients under-
going cardiac surgery represents a greater risk than in earlier
years. In the light of this changing clinical environment, the continu-
ing publication of evidence outlining the value of intra-operative
TOE for adult cardiac surgery, and the conclusion of the most
recent guidelines,35 we concur that TOE is reasonable for use in
all adult patients who are undergoing either cardiac surgery or
thoracic aortic surgical procedures under general anaesthesia.
Recent clinical developments have included the increased use of
catheter-based intracardiac procedures. Whereas septal defect
closure using occluder devices is already well established, trans-
catheter valve procedures, particularly aortic valve replacement
and mitral valve repair are novel procedures being undertaken
with increasing frequency. Many centres perform these procedures
with TOE monitoring, but the exact place for these procedures is
still unclear.
Non-cardiac surgery
Although TOE was first utilized in non-cardiac surgery in 1983 for
the detection of air embolism in neurosurgical patients, since then
cardiac surgery has been the dominant clinical area of use.
However, non-cardiac surgery has been increasingly identified as
a potentially valuable indication for TOE. In neurosurgery, TOE
may be recommended for the detection of venous air embo-
lism.33,37 In liver transplantation, TOE may be recommended for
monitoring cardiac performance, and evaluating cardiac chamber
volume and or compression.38,39 In vascular surgery, the
co-existence of coronary artery disease and high cardiovascular
risk suggests that TOE may be recommended for monitoring and
evaluating left ventricular function as well.40 Numerous studies
and prior guidelines have established that TOE may be valuable
in patients who have unexplained severe hypotension that is unre-
sponsive to standard treatment. Provided the expertise is available,
we recommend that TOE should be used in non-cardiac surgery
patients in this setting. These recommendations should also
apply to major vascular trauma.41,42 The recent guidelines of the
European Society of Cardiology for perioperative cardiac manage-
ment recommend TOE as a diagnostic and monitoring tool in
patients with unexplained haemodynamic deterioration or signs
of myocardial ischaemia during or after non-cardiac surgery.43
A number of studies have evaluated and supported the use of
TOE in orthopaedic surgery (e.g. to detect fat embolism44,45). Fur-
thermore, many orthopaedic patients are frail and elderly and likely
to have significant cardiovascular risk. Although TOE may be rec-
ommended in any patient with significant cardiac disease both for
reasons of diagnosis and to monitor the effects of therapy, we do
not feel that the use of TOE should be recommended routinely for
patients undergoing orthopaedic procedures.
Critical care
The patient recovering from major surgery may experience pro-
blems in the postoperative period. These may be ongoing from
the intra-operative period, or new complications. TOE may be
valuable in identifying or excluding a cardiovascular cause, including
valve lesions, endocarditis, and other consequences of sepsis,
myocardial pump dysfunction, hypovolaemia, cardiac tamponade,
aortic dissection, and intracardiac masses. Critical care patients
do not suffer from the same restrictions concerning contamination
of the operative field that are relevant to patients in the operating
room, and therefore transthoracic imaging is a realistic alternative.
Nonetheless, TOE should be performed in this setting if clinically
relevant information is not obtainable by transthoracic
echocardiography.
Provided that there is appropriate technology available, and that
those charged with undertaking TOE have the knowledge and skills
appropriate to the task, it is therefore recommended that:
† TOE should be used in adult patients undergoing cardiac surgery
or surgery to the thoracic aorta under general anaesthesia, in
particular, in valvular repair procedures.
† TOE may be used in patients undergoing specific types of major
surgery where its value has been repeatedly documented. These
include neurosurgery at risk from venous thromboembolism,
liver transplantation, lung transplantation, and major vascular
surgery, including vascular trauma.
† TOE may be used in patients undergoing major non-cardiac
surgery in whom severe or life-threatening haemodynamic dis-
turbance is either present or threatened.
† TOE may be used in major non-cardiac surgery in patients who
are at a high cardiac risk, including severe cardiac valve
disease, severe coronary heart disease, or heart failure.
† TOE may be used in the critical care patient in whom severe or
life-threatening haemodynamic disturbance is present and unre-
sponsive to treatment, or in patients in whom new or ongoing
cardiac disease is suspected and who are not adequately
assessed by transthoracic imaging or other diagnostic tests.
Importantly, major complications of TOE, including oesophageal
trauma, although rare, are more common among anaesthetised
patients than in those undergoing the procedure under conscious
sedation.46
Conclusion
TOE, a minimal-risk, semi-invasive imaging procedure is nowadays
an indispensable part of routine echocardiography. It provides
unique and well-documented diagnostic advantages in certain clini-
cal scenarios where the image quality of transthoracic echocardio-
graphy is impaired (e.g. the ventilated patient or the patient in the
operating room), and routinely for a number of specific cardiovas-
cular structures and clinical questions (e.g. valvular prosthetic heart
disease, the presence of thrombi in the left atrial appendage, and
diseases of the thoracic aorta).
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